LeMaitre Vascular LMAT
$73.61 −$1.25 (-1.67%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $73.61 0.00%
Open$74.34
Prev close$74.86
Day range$73.44 – $76.44
Volume313.6K
Market cap$1.68B
P/E (TTM)26.8
Dividend yield1.29%
LMAT Stock News
Headlines matching LeMaitre Vascular or the LMAT ticker, most recent first.
- Barrington Upgrades LeMaitre Vascular(LMAT.US) to Buy Rating, Announces Target Price $95 Positive
- Stifel Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $120
- Barrington Downgrades LeMaitre Vascular(LMAT.US) to Hold Rating Negative
- KeyBanc Maintains LeMaitre Vascular(LMAT.US) With Hold Rating
- Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (ARDT), Lemaitre Vascular (LMAT) and Gilead Sciences (GILD)
- Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $120
- A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $120 to $135
- Citizens JMP Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $127 Positive
- Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $120 Positive
- A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $105 to $124
- A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $94 to $118
- Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $95
- A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $91 to $110
- Citizens JMP Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Cuts Target Price to $110 Negative
- Stifel Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Cuts Target Price to $105 Negative
No comments yet — be the first to weigh in on LMAT.
Sign in to join the discussion.